Andrea Ladányi

13PUBLICATIONS
12CO-AUTHORS
Molecular targetsCancer diagnosisApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jul 28, 2026
Importance of Patient-Derived Xenograft Models in Battling Cancer Therapy Resistance.

|May 14, 2025
Clinical Applications of the Molecular Landscape of Melanoma: Integration of Research into Diagnostic and Therapeutic Strategies.

Imre Lőrinc Szabó, Gabriella Emri, Andrea Ladányi

|Jan 08, 2025
Tumor-Infiltrating Immune Cells and HLA Expression as Potential Biomarkers Predicting Response to PD-1 Inhibitor Therapy in Stage IV Melanoma Patients.

Barbara Hegyi, Kristóf György Csikó, Tímea Balatoni

|Dec 23, 2023
Insights into the Tumor Microenvironment-Components, Functions and Therapeutics.

Kornélia Baghy, Andrea Ladányi, Andrea Reszegi

|Dec 23, 2023
p38 Mitogen-Activated Protein Kinase Inhibition of Mesenchymal Transdifferentiated Tumor Cells in Head and Neck Squamous Cell Carcinoma.

Julia Federspiel, Maria do Carmo Greier, Andrea Ladányi

|Jul 29, 2023
Evolving Acquired Vemurafenib Resistance in a BRAF V600E Mutant Melanoma PDTX Model to Reveal New Potential Targets.

József Tóvári, Diána Vári-Mező, Sára Eszter Surguta

Pageof 3

Frequent Collaborators

3 joint publications

Mihály Cserepes

2 joint publications

Soldano Ferrone

1 joint publications

Laura Vízkeleti

1 joint publications

György Vereb